Your Neuroscience CRO Partner for Every Phase of Drug Development

Get Started with a Customized Clinical Solution

Depth of Neurology & Psychiatry Experience

Allucent has conducted a wide range of neuroscience clinical trials, from consulting projects and early phase trials where dose escalation was dependent on repeated CSF sampling and neuroimaging, to worldwide Phase III trials with various interim analyses or adaptive designs.
  • 140+

    Studies

  • 1,990+

    Sites

  • 15,500+

    Patients

  • 720+

    Consulting Projects

Why Allucent?

Anchored by deep expertise and a high-touch partnership model, Allucent delivers operational excellence geared toward Neurology and Psychiatry drug development.

Therapeutic Knowledge

For more than 30 years, Allucent has been at the forefront of neuroscience drug development projects worldwide, with expertise in neurodegenerative, neurological, rare neurological, pain, and psychiatric conditions

Indication Expertise

Our experts specialize in some of the most complex indications including Huntington’s, ALS, DMD, MS, Epilepsy, Addiction, Depression, MDD, and PTSD, to name just a few.

Scientific Innovation

Deep expertise with the development of both traditional and advanced therapies including small molecules, monoclonal antibodies (mAbs), cell & gene therapies, RNA-based therapies, psychedelics, viral vectors, and medical devices

Complex Study Designs

Our experts provide robust and efficient study designs from FIH through to pivotal trials including, defining appropriate and clinically meaningful endpoints, dose optimization, managing placebo response, and long-term follow-up.

CNS Site Network

Comprehensive neuroscience site networks across North America and Europe with experience and expertise in conducting clinical trials across all phases of development, delivering predictable, on-time patient enrollment

Patient Centric

Dedicated Patient Engagement for tailored strategies to support patient recruitment, engagement, diversity and compliance across all clinical study types including, on-site, decentralized, and hybrid trials

Speak With an Expert

Testimonial

We benefited greatly from their deep experience and their professional, yet comfortable working relationship. The most impressive part about working with Allucent is that they can be trusted to deliver what they promise.

SENIOR VICE PRESIDENT OF CLINICAL DEVELOPMENT AND MEDICAL AFFAIRS

Given the complexity of the global regulatory landscape and running cell therapy studies, Allucent made available senior staff with FDA experience and a high degree of expertise all around to help us navigate.

LEADING BIOTECH

Preclinical planning to post-marketing success

We support your neurology and psychiatry drug development journey at every stage

Product Development Strategy & Pre-Clinical

  • Pre-clinical, CMC, and Non-Clinical
  • Gap/Risk Analysis
  • Target Product Profile & Indication
  • Global Regulatory Strategy, Translational Strategy & Modeling

Clinical Development

  • Protocol Design & Dose Optimization
  • Phase I-III Clinical Trials
  • Model Informed Drug Development
  • CTD Authoring & Submissions

Marketing Authorization & Post-Approval

  • Phase IV Clinical Studies
  • Registration & Regulatory Compliance
  • Pharmacovigilance & Medical Information
  • Life Cycle Maintenance

Meet Some of Our Neurology & Psychiatry Drug Development Experts

Lisa Benincosa, PhD
SVP,
Clinical Pharmacology Strategy
Marcus Delatte, PhD
VP,
Regulatory Strategy
Gilad Rosenberg, MD, MSc
Executive Medical Director,
Neuroscience
Maria Jesus Seivane
Global Operations Head,
Neuroscience

About Us

A Fully Integrated Global Company

Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We share small and mid-sized companies’ deep commitment to supporting breakthrough science by partnering with them to navigate the complexities of delivering novel treatments to patients.

With offices across North America, Europe, and the Middle East, Allucent has experience conducting trials in more than 75 countries, focusing on some of the most complex development areas. Globally, Allucent has worked on more than 825 clinical trials, with oncology representing the majority.

Speak with an Expert

Get Started with a Customized Clinical Solution